- $49.19m
- $37.73m
- $62.66m
- 81
- 49
- 13
- 45
Annual cashflow statement for Bioqual, fiscal year end - May 31st, USD millions except per share, conversion factor applied.
2019 May 31st | 2020 May 31st | 2021 May 31st | 2022 May 31st | 2023 May 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 2.83 | 4.23 | 6.33 | 5.26 | 0.836 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.017 | 3.17 | 3.04 | 6.43 | 3.56 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.13 | -4.58 | -8.23 | -13.3 | 1.57 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 1.7 | 4.08 | 2.15 | 0.313 | 8.23 |
| Capital Expenditures | -1.87 | -2.4 | -4.41 | -4.89 | -2.24 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.003 | 0 | 0.709 | 0.154 | 0.002 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.86 | -2.4 | -3.7 | -4.73 | -2.24 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.787 | -0.626 | -0.984 | -1.12 | -0.894 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.953 | 1.05 | -2.54 | -5.54 | 5.1 |